Back to Awarded Treatment Trials
Awarded Trial: 21T-002.a
Grant ID
21T-002.a
Illness
Schizophrenia
Primary Drug/Intervention
Luteolin
Primary Dosage
300 mg BID
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Enrolling
Investigator
Robert Buchanan
Sample Size
33
Duration of Study Period for Each Subject
70 days
Outcome Measurements
PANSS for global psychopathology and positive symptoms Brief Negative Symptom Scale for negative symptoms CGI severity of illness MATRICS Consensus Cognitive Battery (MCCB) to assess neuropsychological test performance. Global Measure of Oxidative Stress Inflammatory Measures Medical Assessments
Results
N/A
Publication
N/A
Link
N/A
PI Name
Robert Buchanan
Degree
N/A
Center
N/A
Institution
University of Maryland Baltimore
Address
620 W. Lexington Street, 4th floor
City or Town
Baltimore
State or Province
Maryland
Zip or Postal Code
21201
Country
United States
Email Address
teamred@ordmail.umaryland.edu